ALS Research Collaboration
  • Home
  • About Us
    • Who we are
    • Our Approach
    • Our Team
    • Our History
  • Our Research
    • Research Focus
    • Participate
    • Studies
    • Current
    • Completed
    • All
    • Publications & Talks
    • Research Vignettes
  • News & Events
  • Support Us
    • Make a donation
  • Contact Us
Select Page

Measuring neurofilament light in human plasma and cerebrospinal fluid: a comparison of five analytical immunoassays.

by Alexandra Grace | Dec 24, 2025

Sheth U, Harrison R, Ferber K, Rosenbaugh EG, Bevis A, Khillan R, Benatar M, Bjorklund NL, Di Daniel E, Harris GA, Kahn OI, Liu Y, Zetterberg H, Mitic LL, Graham D, Gendron TF. Measuring neurofilament light in human plasma and cerebrospinal fluid: a comparison of five...

Generation and characterization of two pluripotent stem cell lines from Primary Lateral Sclerosis (PLS) patients.

by Alexandra Grace | Dec 24, 2025

Laverde-Paz MJ, Maki K, Melo-Escobar I, McCartan R, Benatar M, Wuu J, Zeier Z. Generation and characterization of two pluripotent stem cell lines from Primary Lateral Sclerosis (PLS) patients. Stem Cell Res. 2025 Sep 8;88:103828. Epub 2025 Sep 8. [PubMed link]

Identification of a presymptomatic and early disease signature for amyotrophic lateral sclerosis (ALS): protocol of the premodiALS study.

by Alexandra Grace | Dec 24, 2025

Tzeplaeff L, Galhoz A, Meijs C, Caldi Gomes L, Kovac A, Menzel A, Değirmenci H, Alaamel A, Kaya HC, Çelik AG, Dinçer S, Korucuk M, Karaüzüm SB, Bayraktar E, Çiftçi V, Bilge U, Koç F, Demleitner AF, Buchberger A, von Heynitz R, Gmeiner V, Knellwolf C, Mouzouri M, Wuu...

Design considerations for C9orf72 disease prevention trials.

by Alexandra Grace | Dec 24, 2025

Benatar M, Staffaroni AM, Wuu J, McDermott MP, Quintana M, Swidler J, Andersen G, Huey ED, Turner MR, Macklin EA, Berry JD, McMillan CT, Gendron T, Onyike C, Rosen H, Heuer HW, Grignon AL, Dave KD, Balas C, Gleixner A, Satlin A, Dunn B, Dacks P, Boxer AL. Design...

Proposed research criteria for mild motor impairment as a prodromal syndrome in amyotrophic lateral sclerosis.

by Alexandra Grace | Dec 24, 2025

Benatar M, Cai X, McDermott MP, Granit V, Grignon AL, Colato D, Fernandez MC, Li Y, McBane K, Mesa L, Stanislaw C, Andersen PM, Carberry N, Wuu J. Proposed research criteria for mild motor impairment as a prodromal syndrome in amyotrophic lateral sclerosis. Neurology....
« Older Entries
Next Entries »

Recent Posts

  • Landmark Study Identifies Novel Pre-Symptomatic Biomarkers and Accelerates Progress Towards ALS Prevention
  • July 26, 2026: Miami Marlins Game
  • Feature: UHealth’s Qalsody Clinic Provides Cutting-Edge Care for ALS Patients
  • The New York Times Feature: In a Milestone for A.L.S., a Treatment Helps Some Patients Improve
  • CReATe Author Series Ep. 18 – Dr. Michael Benatar on MMI as a prodromal stage of ALS

Recent Comments

    Latest News

    07/27/26

    Landmark Study Identifies Novel Pre-Symptomatic Biomarkers and Accelerates Progress Towards ALS Prevention

    07/22/26

    July 26, 2026: Miami Marlins Game

    05/26/26

    Feature: UHealth’s Qalsody Clinic Provides Cutting-Edge Care for ALS Patients

    How You Can Help

    Participate in Research

    Make a Donation

    ALS Research Collaboration
    University of Miami,
    Department of Neurology
    1120 NW 14th Street
    Miami, FL 33136

    Search our site

    About Us

    • Who We Are
    • Our Approach
    • Our Team
    • Our History

    Our Research

    • Research Focus
    • Participate
    • All Studies
    • Publications and Talks
    • Research Vignettes

    Support Us

    • Make a Donation

    Search our site

    Copyright 2024 ALS Research Collaboration at University of Miami. All Rights Reserved. Branding by MOK2